AIIMS Mangalagiri Inaugurates AYUSH Department, Plans New Specialty Units
AIIMS Mangalagiri inaugurated its Department of AYUSH on Wednesday, integrating traditional medicine systems with modern healthcare. The institute plans to introduce Yoga, Siddha, Ayurveda Pharmacy, and Panchakarma services, along with new departments for Sports Medicine, Geriatric Medicine, and Biotechnology. These expansions aim to provide specialized care to patients across Andhra Pradesh and neighboring states.
AIIMS Mangalagiri's Executive Director and CEO Ahanthem Santa Singh inaugurated the Department of AYUSH as part of efforts to integrate traditional systems of medicine with modern healthcare practices. The department will soon introduce Yoga and Siddha services, with two additional Medical Officers joining the team. Medical Officer (Ayurveda) Pushpanjali Akula announced that Ayurveda Pharmacy and Panchakarma services would become operational in the near future. Beyond AYUSH, the institute announced plans to establish a Department of Sports Medicine for sportspersons and a Department of Geriatric Medicine to address healthcare needs of elderly populations. Additionally, AIIMS Mangalagiri is collaborating with IIT Tirupati to establish a Department of Biotechnology aimed at strengthening interdisciplinary research and innovation.
What different sources said
- The HinduCenter
AIIMS Mangalagiri inaugurates AYUSH Department, announces new speciality units
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.